AnalystsEva Fortea VerdejoEva Fortea Verdejo's Stock Forecasts
AnalystsEva Fortea Verdejo
Sectors:
Industries:
Analyst Ranking
Top 30%
#1459 out of 4995 analysts
Average Return
+11.47%
Win Rate
75%12 out of 16
Risk vs Reward
Poor
Good
Eva Fortea Verdejo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merus NvMRUS | +57.80% | $42.77 | $67.49 | 2025-05-08 - 2025-08-22 | Strong Buy |
Iteos Therapeutics IncITOS | +46.86% | $6.85 | $10.06 | 2025-04-29 - 2025-05-28 | Strong Buy |
Iteos Therapeutics IncITOS | +41.79% | $7.10 | $10.06 | 2025-03-06 - 2025-05-28 | Strong Buy |
Iteos Therapeutics IncITOS | +39.34% | $7.22 | $10.06 | 2024-12-19 - 2025-05-28 | Strong Buy |
Kiniksa Pharmaceuticals International PLCKNSA | +37.70% | $20.08 | $27.65 | 2024-05-03 - 2025-05-02 | Strong Buy |
Eva Fortea Verdejo Analyst Color
Get additional color on Eva Fortea Verdejo's coverage of popular stocks
Eva Fortea Verdejo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Iteos Therapeutics IncITOS | 7 | Hold | $11.00 | +7.95% | Maintains | 17 days ago |
Xencor IncXNCR | 3 | Strong Buy | $27.00 | +221.05% | Maintains | 17 days ago |
Arcus Biosciences IncRCUS | 3 | Strong Buy | $25.00 | +137.42% | Maintains | 17 days ago |
Kiniksa Pharmaceuticals International PLCKNSA | 2 | Strong Buy | $42.00 | +24.44% | Maintains | 2 months ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $44.00 | +75.16% | Initiates Coverage On | 2 months ago |
Bicara Therapeutics IncBCAX | 2 | Hold | $8.00 | -32.43% | Upgrades | 3 months ago |
Merus NvMRUS | 1 | Strong Buy | $89.00 | +31.87% | Maintains | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.